APA (7th ed.) Citation

Shabil, M., Khatib, M. N., Ballal, S., Bansal, P., Tomar, B. S., Ashraf, A., . . . Bushi, G. (2024). Risk of Hepatocellular Carcinoma with Glucagon-like Peptide-1 receptor agonist treatment in patients: A systematic review and meta-analysis. BMC Endocrine Disorders, 24(1), 1. https://doi.org/10.1186/s12902-024-01775-2

Chicago Style (17th ed.) Citation

Shabil, Muhammed, et al. "Risk of Hepatocellular Carcinoma with Glucagon-like Peptide-1 Receptor Agonist Treatment in Patients: A Systematic Review and Meta-analysis." BMC Endocrine Disorders 24, no. 1 (2024): 1. https://doi.org/10.1186/s12902-024-01775-2.

MLA (9th ed.) Citation

Shabil, Muhammed, et al. "Risk of Hepatocellular Carcinoma with Glucagon-like Peptide-1 Receptor Agonist Treatment in Patients: A Systematic Review and Meta-analysis." BMC Endocrine Disorders, vol. 24, no. 1, 2024, p. 1, https://doi.org/10.1186/s12902-024-01775-2.